Granupas is included for use as part of an appropriate combination regimen for the treatment of multidrug-resistant tuberculosis in adults and children 28 days of age and older when an effective treatment regimen cannot be formulated in this manner for reasons of resistance or tolerability.
Active ingredient: aminosalicylic acid.
Prescription medicine